FibroBiologics Inc. Commo... (FBLG)
NASDAQ: FBLG
· Real-Time Price · USD
0.57
-0.00 (-0.61%)
At close: Aug 18, 2025, 10:41 AM
FibroBiologics Common Stock Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | -1.29 | -1.66 | -5.3 | -51.78 | 36.44 | -11.03 | -21.14 | -107.84 | -109.33 | -98.56 | -134.76 | -151.33 | -201.84 | -201.84 |
PEG Ratio | 0.09 | -0.03 | -0.01 | 0.34 | -0.33 | 0.47 | -0.05 | -71.71 | 11.05 | -2.69 | -10.99 | -4.5 | n/a | n/a |
PS Ratio | n/a | n/a | 118.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 27.95 | 14.05 | 24.04 | 37.84 | -54.83 | -96.64 | 655.64 | 89.72 | 83.25 | -238.27 | -205.59 | n/a | n/a | -636.82 |
P/FCF Ratio | -5.73 | -6.21 | -20.73 | -39.57 | -65.02 | -87.16 | -512.49 | -609.23 | -573.13 | -455.13 | -700.36 | -691.67 | -1.08M | -1.08M |
P/OCF Ratio | -6.03 | -6.26 | -21.4 | -39.74 | -67.22 | -87.33 | -513.13 | -830.13 | -581.59 | -467.65 | -700.36 | -691.67 | -1.08M | -1.08M |
OCF/S Ratio | n/a | n/a | -5.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 12.53 | 3.03 | 3.86 | 0.57 | -0.77 | -0.55 | 1.39 | 0.17 | 0.17 | n/a | -1.88 | n/a | n/a | n/a |
Quick Ratio | 0.93 | 1.14 | 1.12 | 1.23 | 0.64 | 0.64 | 1.00 | 8.31 | 12.48 | n/a | 0.37 | n/a | n/a | n/a |
Current Ratio | 0.93 | 1.14 | 1.12 | 1.23 | 0.64 | 0.64 | 1.00 | 8.31 | 12.48 | n/a | 0.37 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -618.67 | -670.4 | -644.8 | -862.5 | -2.48K | n/a | -190.27 | -16.78 | -5.93 | -6.07 | n/a | n/a |
Return on Equity | -5.42 | -2.11 | -1.13 | -0.18 | -0.38 | 2.19 | -7.75 | -0.21 | -0.19 | 0.60 | 0.38 | n/a | n/a | 0.79 |
Return on Assets | -0.33 | -0.43 | -0.19 | -0.05 | 0.10 | -0.74 | -0.82 | -0.16 | -0.16 | n/a | -0.32 | n/a | n/a | n/a |
Return on Invested Capital | -0.39 | -0.48 | -0.28 | -0.78 | 5.85 | 1.97 | -0.83 | -0.17 | -0.15 | n/a | -0.37 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -5.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -5.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -6.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -5.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |